Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

4.05
Delayed Data
As of Apr 21
 +0.10 / +2.53%
Today’s Change
1.10
Today|||52-Week Range
5.30
+200.00%
Year-to-Date
The Best Timeframe Right Now Is the Intraday Trade
Apr 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close3.95
Today’s open4.05
Day’s range3.90 - 4.15
Volume374,667
Average volume (3 months)371,121
Market cap$76.7M
Dividend yield--
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)+48.98%
Earnings growth (this year)+48.00%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+49.94%
P/E ratioNM
Price/Sales0.79
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc-0.05-2.62%
GALTGalectin Therapeutic...-0.14-4.33%
TRILTrillium Therapeutic...0.000.00%
INISInternational Isotop...-0.00-5.26%
Data as of 2:07pm ET, 04/21/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$27.0M
Annual profit (last year)-$15.8M
Net profit margin-58.42%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Chief Operating Officer &
Executive VP-Finance
John A. Roberts
Corporate headquarters
Rutherford, New Jersey

Forecasts


Search for Jobs